$MBVX MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trading Week 14/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MABVAX THERAPEUTICS HOLDINGS, INC. in week 14/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Scholz Wolfgang W. | VP OF ANTIBODY DISC ... | Option Exercise | M | 0.00 | 101,584 | 0 | 203,166 | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Scholz Wolfgang W. | VP OF ANTIBODY DISC ... | Payment of Exercise | F | 0.00 | 38,320 | 0 | 113,288 | 151.6 K to 113.3 K (-25.28 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Scholz Wolfgang W. | VP OF ANTIBODY DISC ... | Buy | M | 0.00 | 101,584 | 0 | 151,608 | 50 K to 151.6 K (+203.07 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | M | 0.00 | 11,417 | 0 | 22,833 | ||
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Buy | M | 0.00 | 11,417 | 0 | 21,417 | 10 K to 21.4 K (+114.17 %) | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Option Exercise | M | 0.00 | 11,417 | 0 | 22,833 | ||
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Buy | M | 0.00 | 11,417 | 0 | 11,417 | 0 to 11.4 K | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Ravetch Jeffrey V. | Option Exercise | M | 0.00 | 11,417 | 0 | 22,833 | ||
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Ravetch Jeffrey V. | Buy | M | 0.00 | 11,417 | 0 | 11,417 | 0 to 11.4 K | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | M | 0.00 | 11,417 | 0 | 22,833 | ||
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Buy | M | 0.00 | 11,417 | 0 | 16,417 | 5 K to 16.4 K (+228.34 %) | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Option Exercise | M | 0.00 | 11,417 | 0 | 22,833 | ||
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Buy | M | 0.00 | 11,417 | 0 | 11,417 | 0 to 11.4 K | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | M | 0.00 | 301,184 | 0 | 602,166 | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Payment of Exercise | F | 0.00 | 113,148 | 0 | 254,634 | 367.8 K to 254.6 K (-30.76 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Buy | M | 0.00 | 301,084 | 0 | 367,782 | 66.7 K to 367.8 K (+451.41 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | M | 0.00 | 111,334 | 0 | 222,666 | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Payment of Exercise | F | 0.00 | 40,944 | 0 | 75,390 | 116.3 K to 75.4 K (-35.20 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | M | 0.00 | 111,334 | 0 | 116,334 | 5 K to 116.3 K (+2,226.68 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 155,867 | 0 | 311,733 | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Payment of Exercise | F | 0.00 | 58,044 | 0 | 100,823 | 158.9 K to 100.8 K (-36.54 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 155,867 | 0 | 158,867 | 3 K to 158.9 K (+5,195.57 %) |